InvestorsHub Logo
Followers 12
Posts 713
Boards Moderated 0
Alias Born 05/22/2012

Re: Saltz post# 131365

Thursday, 12/03/2020 1:02:20 PM

Thursday, December 03, 2020 1:02:20 PM

Post# of 232058
S/C will tail like M/M
HIV BLA submission probably happens but that market is very small and there are numerous drugs including this new GILD drug that is Sub-q
https://www.gilead.com/news-and-press/press-room/press-releases/2020/11/gilead-announces-investigational-longacting-hiv1-capsid-inhibitor-lenacapavir-achieves-primary-endpoint-in-phase-23-study-in-heavily-treatmentex

Even if they get the BLA approved its a $50mm end market and the current EV is $1.5B.. If they become successful in HIV the company EV should be $100mm or so which makes this stock about $0.10
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News